Furthermore, in glioma, Jeon et al. [32] found a new Id4-miR-9-SOX2 regulatory pathway that could affect the self-renewal activity of glioma cells, the chemoresistance of glioma stem cell (GSCs), and the maintenance of the stemness of induced GSCs. The gene discussed is SOX2; the disease is glioma.